In phase 2 trials, cendifensine significantly reduced the frequency and severity of menopausal hot flashes and may offer broader symptom relief benefits.
Rebecca Dunsmoor-Su, MD
Advertisement
Rebecca Dunsmoor-Su, MD, is the Chief Medical Officer for Gennev.
Articles by Rebecca Dunsmoor-Su, MD
Advertisement
Latest Updated Articles
Rebecca Dunsmoor-Su, MD, highlights reduced hot flashes from cendifensinePublished: December 4th 2025 | Updated:
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
American Academy of Pediatrics releases 2026 childhood immunization schedule
2
Menopause associated with adverse mental health, reduced grey matter volume
3
Aviva to advance, announce new data for AVA-291 women's testosterone therapy
4
Rheumatoid arthritis deaths among postmenopausal women decline from 1999 to 2023
5